Research Paper Volume 11, Issue 14 pp 4858—4875
CCAT1 promotes triple-negative breast cancer progression by suppressing miR-218/ZFX signaling
Figure 8. CCAT1 promotes tumor growth in a xenograft mouse model of TNBC. (A, B) Xenograft tumor volume was measured every 5 days among the different treatment groups consisting of MDA-MB-231 or MDA-MB-468 cells transfected with si-control, si-CCAT1, pcDNA-control, or pcDNA-CCAT1. (C) Comparison of tumor weight between groups. *P < 0.05 compared to controls.